Treatment and prevention of ventricular fibrillation: are there better agents?
Clinical Pharmacology Group, Southampton General Hospital.
D G
DG
Waller
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001949:Bretylium Compounds / Q000627:therapeutic use; D016887:Cardiopulmonary Resuscitation; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D014693:Ventricular Fibrillation / Q000517:prevention & control*
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D001949:Bretylium Compounds; D008012:Lidocaine; C045166:bretylium